HEMATOXYLIN

HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.

Cross Reference

Introduction

To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with HEMATOXYLIN?

HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN

MeSH term MeSH ID Detail
Tuberculosis D014376 20 associated lipids
Stomach Ulcer D013276 75 associated lipids
Diarrhea D003967 32 associated lipids
Uterine Cervical Neoplasms D002583 10 associated lipids
Carcinoma, Basal Cell D002280 6 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Tumor Virus Infections D014412 8 associated lipids
Adenocarcinoma D000230 166 associated lipids
Breast Neoplasms D001943 24 associated lipids
Sarcoma D012509 3 associated lipids
Bacterial Infections D001424 21 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Mouth Diseases D009059 5 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Skin Neoplasms D012878 12 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Per page 10 20 50 100 | Total 146

PubChem Associated disorders and diseases

What pathways are associated with HEMATOXYLIN

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with HEMATOXYLIN?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with HEMATOXYLIN?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

What genes are associated with HEMATOXYLIN?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with HEMATOXYLIN

Download all related citations
Per page 10 20 50 100 | Total 5340
Authors Title Published Journal PubMed Link
Shaw MB et al. A porcine model of bladder outlet obstruction incorporating radio-telemetered cystometry. 2007 BJU Int. pmid:17552964
Phull H et al. Angiotensin II plays a role in acute murine experimental autoimmune cystitis. 2007 BJU Int. pmid:17550411
Hafez AT et al. Healing of unstented tubularized incised plate urethroplasty: an experimental study in a rabbit model. 2003 BJU Int. pmid:12614257
Breda A et al. Comparison of accuracy of 14-, 18- and 20-G needles in ex-vivo renal mass biopsy: a prospective, blinded study. 2010 BJU Int. pmid:19888984
Hattori K et al. Chemopreventive effects of cyclooxygenase-2 inhibitor and epidermal growth factor-receptor kinase inhibitor on rat urinary bladder carcinogenesis. 2006 BJU Int. pmid:16469040
Craatz S et al. The dorsal lamina of the rectus sheath: a suitable grafting material for the penile tunica albuginea in Peyronie's disease? 2006 BJU Int. pmid:16336343
Costello AJ et al. Immunohistochemical study of the cavernous nerves in the periprostatic region. 2011 BJU Int. pmid:20942832
Zelhof B et al. Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer. 2009 BJU Int. pmid:19007373
El-Assmy A et al. Use of oxidized cellulose for corporal body grafting and suture-less correction of severe penile chordee: an experimental study in rabbits. 2007 BJU Int. pmid:17233810
Sokoloff MH et al. Characterizing prostatic adenocarcinomas in men with a serum prostate specific antigen level of < 4.0 ng/mL. 2004 BJU Int. pmid:15008717
Dasgupta P et al. Cimetidine in painful bladder syndrome: a histopathological study. 2001 BJU Int. pmid:11488726
Liu MI and Hutson JM Ontogeny of bladder agenesis in rats induced by adriamycin. 2001 BJU Int. pmid:11298057
Tewari A et al. Identification of the retrotrigonal layer as a key anatomical landmark during robotically assisted radical prostatectomy. 2006 BJU Int. pmid:16879447
Donovan MJ et al. A systems-based modelling approach using transurethral resection of the prostate (TURP) specimens yielded incremental prognostic significance to Gleason when predicting long-term outcome in men with localized prostate cancer. 2012 BJU Int. pmid:21733075
Metcalfe PD et al. Bladder outlet obstruction: progression from inflammation to fibrosis. 2010 BJU Int. pmid:20590549
al-Saleem T Classification of lymphoid neoplasms between the hematopathologists and the "common person". 1995 Blood pmid:7535596
Conway CM et al. The development and validation of the Virtual Tissue Matrix, a software application that facilitates the review of tissue microarrays on line. 2006 BMC Bioinformatics pmid:16707006
Kovacheva VN et al. A model of the spatial tumour heterogeneity in colorectal adenocarcinoma tissue. 2016 BMC Bioinformatics pmid:27342072
Wang CW Fast automatic quantitative cell replication with fluorescent live cell imaging. 2012 BMC Bioinformatics pmid:22292799
Mete M et al. Automatic delineation of malignancy in histopathological head and neck slides. 2007 BMC Bioinformatics pmid:18047716
Hejnol A and Martindale MQ Coordinated spatial and temporal expression of Hox genes during embryogenesis in the acoel Convolutriloba longifissura. 2009 BMC Biol. pmid:19796382
Sabbir MG et al. Identification and characterization of Dlc1 isoforms in the mouse and study of the biological function of a single gene trapped isoform. 2010 BMC Biol. pmid:20199662
Carmona FD et al. The molecular basis of defective lens development in the Iberian mole. 2008 BMC Biol. pmid:18939978
Pask AJ et al. Oestrogen blocks the nuclear entry of SOX9 in the developing gonad of a marsupial mammal. 2010 BMC Biol. pmid:20807406
Zaibak F et al. Unrestricted somatic stem cells from human umbilical cord blood grow in serum-free medium as spheres. 2009 BMC Biotechnol. pmid:20003538
Takano EA et al. A multiplex endpoint RT-PCR assay for quality assessment of RNA extracted from formalin-fixed paraffin-embedded tissues. 2010 BMC Biotechnol. pmid:21162754
Martin CD et al. A simple vector system to improve performance and utilisation of recombinant antibodies. 2006 BMC Biotechnol. pmid:17156422
Costa-Nogueira C et al. Synthesis and expression of CDw75 antigen in human colorectal cancer. 2009 BMC Cancer pmid:20003255
Fritzsche FR et al. ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression. 2008 BMC Cancer pmid:18582378
Skandalis SS et al. Versican but not decorin accumulation is related to malignancy in mammographically detected high density and malignant-appearing microcalcifications in non-palpable breast carcinomas. 2011 BMC Cancer pmid:21791066
Ioachim E et al. Thrombospondin-1 expression in urothelial carcinoma: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components. 2006 BMC Cancer pmid:16732887
Zhang B et al. Expression of RECK and matrix metalloproteinase-2 in ameloblastoma. 2009 BMC Cancer pmid:19995435
El Khoury D et al. Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice. 2010 BMC Cancer pmid:20573279
Rubie C et al. ELR+ CXC chemokine expression in benign and malignant colorectal conditions. 2008 BMC Cancer pmid:18578857
Ohri CM et al. Tumour necrosis factor-alpha expression in tumour islets confers a survival advantage in non-small cell lung cancer. 2010 BMC Cancer pmid:20573209
Sanz-Santos J et al. Contribution of cell blocks obtained through endobronchial ultrasound-guided transbronchial needle aspiration to the diagnosis of lung cancer. 2012 BMC Cancer pmid:22264305
Alam H et al. Fascin overexpression promotes neoplastic progression in oral squamous cell carcinoma. 2012 BMC Cancer pmid:22264292
de Kruijf EM et al. NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study. 2012 BMC Cancer pmid:22257486
Kalinina T et al. Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung. 2010 BMC Cancer pmid:20553613
Kim JH et al. Canine classical seminoma: a specific malignant type with human classifications is highly correlated with tumor angiogenesis. 2010 BMC Cancer pmid:20509912
Di Nicolantonio F et al. Cancer cell adaptation to chemotherapy. 2005 BMC Cancer pmid:16026610
Egerod FL et al. High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression. 2009 BMC Cancer pmid:19878561
van Rossum AG et al. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice. 2006 BMC Cancer pmid:16536875
Kalliomäki TM et al. Analysis of the effects of exposure to acute hypoxia on oxidative lesions and tumour progression in a transgenic mouse breast cancer model. 2008 BMC Cancer pmid:18507854
Yan T et al. Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide. 2011 BMC Cancer pmid:22185371
Kratz JE et al. Expression of stabilized beta-catenin in differentiated neurons of transgenic mice does not result in tumor formation. 2002 BMC Cancer pmid:12460454
Meyniel JP et al. A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer. 2010 BMC Cancer pmid:20492709
Zhang D et al. Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study. 2010 BMC Cancer pmid:21108842
Nykopp TK et al. Expression of hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in serous ovarian carcinomas: inverse correlation between HYAL1 and hyaluronan content. 2009 BMC Cancer pmid:19435493
Ohri CM et al. Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer. 2010 BMC Cancer pmid:20429924
Tong QS et al. BAK overexpression mediates p53-independent apoptosis inducing effects on human gastric cancer cells. 2004 BMC Cancer pmid:15248898
Morrone FB et al. In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model. 2006 BMC Cancer pmid:16995949
Chanrion M et al. A new molecular breast cancer subclass defined from a large scale real-time quantitative RT-PCR study. 2007 BMC Cancer pmid:17338809
Tuomela J et al. Fast growth associated with aberrant vasculature and hypoxia in fibroblast growth factor 8b (FGF8b) over-expressing PC-3 prostate tumour xenografts. 2010 BMC Cancer pmid:21034500
Nordfors K et al. The tumour-associated carbonic anhydrases CA II, CA IX and CA XII in a group of medulloblastomas and supratentorial primitive neuroectodermal tumours: an association of CA IX with poor prognosis. 2010 BMC Cancer pmid:20398423
Valencia T et al. Role and expression of FRS2 and FRS3 in prostate cancer. 2011 BMC Cancer pmid:22078327
Wu Z et al. Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma. 2009 BMC Cancer pmid:19732464
Hadad SM et al. Histological evaluation of AMPK signalling in primary breast cancer. 2009 BMC Cancer pmid:19723334
Machado CM et al. Characterization of cells recovered from the xenotransplanted NG97 human-derived glioma cell line subcultured in a long-term in vitro. 2008 BMC Cancer pmid:18840301
Sun S et al. A protein-based set of reference markers for liver tissues and hepatocellular carcinoma. 2009 BMC Cancer pmid:19725976
Nordentoft I et al. Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer. 2011 BMC Cancer pmid:21489314
ten Haaf A et al. Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival. 2009 BMC Cancer pmid:19706168
Woelber L et al. Carbonic anhydrase IX in tumor tissue and sera of patients with primary cervical cancer. 2011 BMC Cancer pmid:21223596
Deschoolmeester V et al. Detection of HPV and the role of p16INK4A overexpression as a surrogate marker for the presence of functional HPV oncoprotein E7 in colorectal cancer. 2010 BMC Cancer pmid:20346145
Szybka M et al. cDNA sequencing improves the detection of P53 missense mutations in colorectal cancer. 2009 BMC Cancer pmid:19671129
Shi H et al. Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis. 2010 BMC Cancer pmid:20815902
Kempkensteffen C et al. Down-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancer. 2009 BMC Cancer pmid:19664236
Spindler KL et al. EGFR related mutational status and association to clinical outcome of third-line cetuximab-irinotecan in metastatic colorectal cancer. 2011 BMC Cancer pmid:21439039
Liu J et al. Alterations of BCCIP, a BRCA2 interacting protein, in astrocytomas. 2009 BMC Cancer pmid:19653894
Aloysius MM et al. Immunohistochemical expression of mitochondrial membrane complexes (MMCs) I, III, IV and V in malignant and benign periampullary epithelium: a potential target for drug therapy of periampullary cancer? 2010 BMC Cancer pmid:20202214
Naguib A et al. Dietary, lifestyle and clinicopathological factors associated with BRAF and K-ras mutations arising in distinct subsets of colorectal cancers in the EPIC Norfolk study. 2010 BMC Cancer pmid:20233436
Lööf J et al. Impact of PINCH expression on survival in colorectal cancer patients. 2011 BMC Cancer pmid:21426571
Van der Auwera I et al. Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients. 2010 BMC Cancer pmid:20226036
Nyalendo C et al. Identification of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation in association with neuroblastoma progression. 2009 BMC Cancer pmid:19961596
Tomlinson VA et al. Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours. 2005 BMC Cancer pmid:16156888
Cheng Y et al. Proteome analysis of human gastric cardia adenocarcinoma by laser capture microdissection. 2007 BMC Cancer pmid:17927838
Gockel I et al. Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma. 2006 BMC Cancer pmid:17176471
García N et al. A molecular analysis by gene expression profiling reveals Bik/NBK overexpression in sporadic breast tumor samples of Mexican females. 2005 BMC Cancer pmid:16060964
Mascolo M et al. Overexpression of Chromatin Assembly Factor-1/p60 helps to predict the prognosis of melanoma patients. 2010 BMC Cancer pmid:20178651
Hungermann D et al. Adenomyoepithelial tumours and myoepithelial carcinomas of the breast--a spectrum of monophasic and biphasic tumours dominated by immature myoepithelial cells. 2005 BMC Cancer pmid:16050957
Malfettone A et al. Peritumoral vascular invasion and NHERF1 expression define an immunophenotype of grade 2 invasive breast cancer associated with poor prognosis. 2012 BMC Cancer pmid:22439624
Jörissen H et al. Production and characterisation of monoclonal antibodies against RAI3 and its expression in human breast cancer. 2009 BMC Cancer pmid:19552806
Arellano-Llamas A et al. High Smac/DIABLO expression is associated with early local recurrence of cervical cancer. 2006 BMC Cancer pmid:17067390
Genelhu MC et al. A comparative study between mixed-type tumours from human salivary and canine mammary glands. 2007 BMC Cancer pmid:18045453
van Cruijsen H et al. Tissue micro array analysis of ganglioside N-glycolyl GM3 expression and signal transducer and activator of transcription (STAT)-3 activation in relation to dendritic cell infiltration and microvessel density in non-small cell lung cancer. 2009 BMC Cancer pmid:19519895
Sheahan S et al. Deficiency of G1 regulators P53, P21Cip1 and/or pRb decreases hepatocyte sensitivity to TGFbeta cell cycle arrest. 2007 BMC Cancer pmid:18021445
van Houwelingen KP et al. Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study. 2005 BMC Cancer pmid:15932632
Dierssen JW et al. High-resolution analysis of HLA class I alterations in colorectal cancer. 2006 BMC Cancer pmid:17014712
Hamma-Kourbali Y et al. The synthetic peptide P111-136 derived from the C-terminal domain of heparin affin regulatory peptide inhibits tumour growth of prostate cancer PC-3 cells. 2011 BMC Cancer pmid:21624116
Gonzalez LO et al. Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors. 2008 BMC Cancer pmid:18507821
Kumar MJ et al. A mouse model for luminal epithelial like ER positive subtype of human breast cancer. 2007 BMC Cancer pmid:17880731
Seigne C et al. Characterisation of prostate cancer lesions in heterozygous Men1 mutant mice. 2010 BMC Cancer pmid:20663219
Boström P et al. MMP-1 expression has an independent prognostic value in breast cancer. 2011 BMC Cancer pmid:21835023
Slipicevic A et al. Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival. 2012 BMC Cancer pmid:22356677
Xiaorong L et al. Underexpression of deleted in liver cancer 2 (DLC2) is associated with overexpression of RhoA and poor prognosis in hepatocellular carcinoma. 2008 BMC Cancer pmid:18651974
Webb M et al. Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis. 2005 BMC Cancer pmid:15717926
Wang J et al. A reproducible brain tumour model established from human glioblastoma biopsies. 2009 BMC Cancer pmid:20040089
Bacman D et al. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study. 2007 BMC Cancer pmid:17692120
Wang J et al. Case report: PET/CT, a cautionary tale. 2007 BMC Cancer pmid:17683560
Macartney-Coxson DP et al. Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level. 2008 BMC Cancer pmid:18590575